Oak Street Health, Inc.
OSH · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.52 | -0.17 | -1.12 | -1.65 |
| FCF Yield | -8.05% | -3.78% | -0.73% | -1.02% |
| EV / EBITDA | -13.01 | -21.04 | -75.40 | -85.65 |
| Quality | ||||
| ROIC | -42.71% | -35.01% | -39.38% | -127.65% |
| Gross Margin | 3.61% | 2.09% | 8.77% | 5.35% |
| Cash Conversion Ratio | 0.61 | 0.48 | 0.40 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 34.77% | 37.04% | 40.55% | 8,225,775.04% |
| Free Cash Flow Growth | -43.12% | -183.89% | -17.84% | 17.91% |
| Safety | ||||
| Net Debt / EBITDA | -2.52 | -2.43 | 2.35 | -0.56 |
| Interest Coverage | -186.48 | -165.60 | -21.07 | -18.38 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 54.61 |
| Cash Conversion Cycle | -2.57 | -4.96 | -0.85 | 109.50 |